Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 4/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | STAT3 | P40763 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | CHRNA7 | P36544 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.65 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.65 |
| ▸ | CES2 | O00748 | 2/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Levomenol SCHEMBL12414344 | 1.00 | ALOX15 (1.00) | ALOX15CYP3A4STAT3MEN1MAPK1 | |
| Levomenol SCHEMBL24988 | 1.00 | ALOX15 (1.00) | ALOX15CYP3A4STAT3MEN1MAPK1 | |
| Levomenol SCHEMBL2728600 | 1.00 | ALOX15 (1.00) | ALOX15CYP3A4STAT3MEN1MAPK1 | |
| Levomenol SCHEMBL24989 | 1.00 | ALOX15 (1.00) | ALOX15CYP3A4STAT3MEN1MAPK1 | |
| Levomenol SCHEMBL31157846 | 1.00 | ALOX15 (1.00) | ALOX15CYP3A4STAT3MEN1MAPK1 | |
| Levomenol SCHEMBL14515491 | 1.00 | ALOX15 (1.00) | ALOX15CYP3A4STAT3MEN1MAPK1 | |
| Bisabolol SCHEMBL13220166 | 1.00 | ALOX15 (1.00) | ALOX15CYP3A4STAT3MEN1MAPK1 | |
| Levomenol SCHEMBL1245143 | 1.00 | ALOX15 (1.00) | ALOX15CYP3A4STAT3MEN1MAPK1 | |
| Levomenol SCHEMBL20838984 | 1.00 | ALOX15 (1.00) | ALOX15CYP3A4STAT3MEN1MAPK1 | |
| Levomenol SCHEMBL172398 | 1.00 | ALOX15 (1.00) | ALOX15CYP3A4STAT3MEN1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090169652-A1 | Personal Care Compositions | THE PROCTER & GAMBLE COMPANY | 2009-07-02 | — | — | US | claimed |
| US-20230338250-A1 | Compositions Comprising One or More (Bio)-Alkanediols with Active Ingredients | SYMRISE AG (DE) | 2023-10-26 | — | — | US | disclosed |
| US-20200206231-A1 | TOPICAL PHARMACEUTICAL COMPOSITION, METHOD FOR PRODUCING THE TOPICAL PHARMACEUTICAL COMPOSITION, USE OF TOPICAL PHARMACEUTICAL COMPOSITION AND METHOD FOR TOPICAL TREATMENT OF PSORIASIS, ATOPIC DERMATITIS OR CHRONIC ECZEMA | BIOLAB SANUS FARMACEUTICA LTDA (BR) | 2020-07-02 | — | — | US | disclosed |
| US-20140299149-A1 | COMPOSITIONS AND METHODS FOR TREATING KERATIN BASED FIBERS | COOLWAY INC (US) | 2014-10-09 | — | — | US | disclosed |
| US-20090169652-A1 | Personal Care Compositions | THE PROCTER & GAMBLE COMPANY | 2009-07-02 | — | — | US | disclosed |
| US-20050025847-A1 | Microbicidal compositions and method of use | PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH (US) | 2005-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200206231-A1 | TOPICAL PHARMACEUTICAL COMPOSITION, METHOD FOR PRODUCING THE TOPICAL PHARMACEUTICAL COMPOSITION, USE OF TOPICAL PHARMACEUTICAL COMPOSITION AND METHOD FOR TOPICAL TREATMENT OF PSORIASIS, ATOPIC DERMATITIS OR CHRONIC ECZEMA | MTX1, MTX2, IL17A | ALOX15 352/4885CYP3A4 499/4885STAT3 2751/4885 |
| US-20090169652-A1 | Personal Care Compositions | CUTA, C5, F7 | ALOX15 370/4885CYP3A4 4006/4885STAT3 4420/4885 |
| US-20230338250-A1 | Compositions Comprising One or More (Bio)-Alkanediols with Active Ingredients | DERL1, DHCR7, DHCR24 | ALOX15 143/4885CYP3A4 1783/4885STAT3 4093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.